Form D · Private Equity Fund
OrbiMed Royalty & Credit Opportunities IV, LP
New York, NY · CIK 0001920649
Offering snapshot reported Dec 16, 2022 · SEC filing
- Reported sold
- $1.15B Offering amount: $1.75B
- Investors reported
- 113 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 113
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2022 | Amendment | $1,153,124,600 | No comparison | 113 | SEC filing |
| Apr 28, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-443752
The total amount sold includes capital committed by the General Partner.
Paid based on percentage of committed capital of investors introduced by selling agent. Management fees will be offset by any such amounts paid by the Issuer. Such amounts do not reduce the offering proceeds available for investment.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| J.P. Morgan Securities LLC | 79 |
Source: Form D, filed Dec 16, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Investment adviser: ORBIMED ADVISORS LLC
- Gross asset value
- $1.42B
- Beneficial owners
- 495
- ADV minimum commitment
- $1M
Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
KPMG LLP
PCAOB 185
Filing source
Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-9066756846
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David P. Bonita | Executive |
| Sven H. Borho | Executive |
| Carl L. Gordon | Executive |
| Geoffrey C. Hsu | Executive |
| W. Carter Neild | Executive |
| N/A Orbi Med Advisors Llc | Executive |
| N/A Orbi Med Rof Iv Llc | Executive |
| Matthew S. Rizzo | Executive |
| C. Scotland Stevens | Executive |
| Peter A. Thompson | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022